NKTX vs SRPT · $188.9M cap vs rev $1.13B
Nkarta Inc (NKTX) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Nkarta Inc (NKTX) is a biotechnology company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported NKTX revenue for 2025-12-31 was $0. Net income was -$104.1M. NKTX currently screens at market cap $188.9M.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
NKTX currently screens at market cap $188.9M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the NKTX and SRPT stock pages for the full models.
Not investment advice.